← FDA Drug Approvals (Drugs@FDA)

SILDENAFIL CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2016-06-20

Drug application

FDA Application #
ANDA204883
Application type
Abbreviated New Drug Application (Generic)
Brand name
SILDENAFIL CITRATE
Generic name
SILDENAFIL
Active ingredients
SILDENAFIL CITRATE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
RUBICON RESEARCH
Manufacturer
TruPharma LLC
First approval
2016-06-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown